MKM Partners Remains Bullish on Advanced Micro Devices (AMD) Following Strong 2Q

Pre-Open Stock Movers 07/22: (PBYI) (EYES) (PFPT) (AMD) Higher; (OPTT) (OLN) (SKX) Lower (more...)

July 22, 2016 9:29 AM EDT

Today's Pre-Open Stock Movers

Puma Biotechnology, Inc. (NYSE: PBYI) 19.8% HIGHER; submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for its lead product candidate PB272 (neratinib) for the extended adjuvant treatment of patients with early stage HER2-overexpressed/amplified breast cancer who have received prior adjuvant trastuzumab (Herceptin®)-based therapy. Also, announced updated results from the Phase III clinical trial of Pumas investigational drug PB272 (neratinib) for the extended adjuvant treatment of... More

Advanced Micro Devices (AMD): More Upside to Come - Jefferies

July 22, 2016 9:22 AM EDT

Jefferies analyst, Mark Lipacis, reiterated his Buy rating on shares of AMD (NASDAQ: AMD) noting AMD's EV/S ratio has increased from a trough of 0.3x in late 2012, to 1.5x recently, but he thinks there is more to go for 3 reasons:

1) GPU use cases are... More

AMD (AMD) PT Lifted to $5.50 at Mizuho But Remains Sidelined

July 22, 2016 7:13 AM EDT

Mizuho Securities analyst Vijay Rakesh raised its price target on AMD (NASDAQ: AMD) to $5.50 (from $4.50) following results but maintained a Neutral rating.

Rakesh commented, "AMD reported 2Q16 Rev/EPS inline with consensus. Strength was driven by its lower margin Semi custom SoCs and... More

Stocks with Implied Volatility Movement

July 22, 2016 5:09 AM EDT

Advanced Micro Devices (NASDAQ: AMD) had wide implied volatility movement

... More

After-Hours Stock Movers 07/21 (PBYI) (EYES) (PFPT) Higher; (SKX) (ATHN) (P) Lower (more...)

July 21, 2016 5:59 PM EDT

Today's After-Hours Movers

Puma Biotechnology, Inc. (NYSE: PBYI) 18.8% HIGHER; submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for its lead product candidate PB272 (neratinib) for the extended adjuvant treatment of patients with early stage HER2-overexpressed/amplified breast cancer who have received prior adjuvant trastuzumab (Herceptin®)-based therapy. Also, announced updated results from the Phase III clinical trial of Pumas investigational drug PB272 (neratinib) for the extended adjuvant treatment of HER2-positive early stage breast cancer (ExteNET trial). The ExteNET trial is a... More

Advanced Micro Devices (AMD) Tops Q2 EPS by 3c

July 21, 2016 4:17 PM EDT

Advanced Micro Devices (NASDAQ: AMD) reported Q2 EPS of ($0.05), $0.03 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $1.03 billion versus the consensus estimate of $951.29 million.

"In the second quarter we accomplished a significant milestone as we returned to non-GAAP... More

Advanced Micro Devices (AMD) Shares Hover at Session Lows into Q2 Report

July 21, 2016 3:16 PM EDT

Advanced Micro Devices (NASDAQ: AMD) shares are trading to session lows ahead of the company's Q2 report, which is expected out after markets close.

Consensus estimates call for... More

Trading Radar for 7/21: GM (GM), Chipotle (CMG), AMD (AMD), Starbucks (SBUX), Pandora (P), Visa (V), Travelers (TRV) Report

July 20, 2016 2:39 PM EDT

The Trading Radar highlights key earnings and economic announcements for the next trading session:

Before Markets Open:
Economics:
8:30am EDT

Initial Claims - Street sees 265kContinuing Claims - no Street consensusPhiladelphia Fed - Street sees 5.0

9:00am EDT

FHFA Housing Price Index - no Street consensus

Earnings:

ABB Ltd. (NYSE: ABB) - consensus EPS $0.26
Adeptus Health (NYSE: ADPT) - consensus EPS $0.51
Alaska Air Group (NYSE: ALK) - consensus EPS $2.07... More